28 Jun 2026

CRC Research Update — June 28, 2026

Creator: The CRC Digest
Published: 2026-06-28T12:28:08Z

Today's colorectal cancer research highlights

Was this forwarded to you? Read on the web or subscribe free

IMPORTANT: The CRC Digest curates and summarizes publicly available research for informational and educational purposes only. Nothing in this newsletter constitutes medical advice, diagnosis, or treatment recommendation. The information provided should not be used as a substitute for professional medical advice. Always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition or treatment. Content is generated with AI assistance and reviewed by the editorial team. We are not medical professionals. Individual results, treatments, and outcomes vary.

Signal Key

TRIAL DATA clinical trial results, efficacy data, survival endpoints TREATMENT new treatment options, regimen changes, combination therapies REGULATORY FDA/EMA approvals, guideline updates, NCCN/ESMO changes RESEARCH cancer biology, biomarker discoveries, resistance pathways SCREENING screening, colonoscopy guidelines, liquid biopsy, molecular profiling LIVING WITH CRC survivorship, quality of life, side effects, patient decision-making, caregiver support

CRC Research Update

AI-assisted colonoscopy improves adenoma detection across 42 studies
A meta-analysis of 42 studies found that artificial intelligence–assisted colonoscopy improves detection of adenomas—precancerous polyps that can develop into colorectal cancer. (Journal of Clinical Oncology)
AI colonoscopy reduces missed adenomas and sessile serrated lesions
An updated systematic review and meta-analysis shows AI-assisted colonoscopy helps detect adenomas and sessile serrated lesions that might otherwise be missed during screening. (Journal of Clinical Oncology)
Wearable devices may predict treatment side effects in colorectal cancer
A study of 720 patients with breast, lung, or colorectal cancer found that wearable-derived measures like heart rate variability, daily steps, and sleep efficiency may help predict severe treatment toxicity and survival beyond standard clinical assessments. (Critical Reviews in Oncology/Hematology)
Specialized CT imaging may predict prognosis in stage II colorectal cancer
A study of 153 stage II colorectal cancer patients found that dual-layer spectral detector CT quantitative parameters may non-invasively predict tumor budding grade—a critical prognostic biomarker—and three-year disease-free survival before surgery. (Academic Radiology)

🔎 Screening Watch

Screening guidelines, early detection, and prevention advances

AI-assisted colonoscopy improves adenoma detection
Meta-analysis of 42 studies confirms AI assistance during colonoscopy improves detection of precancerous polyps. (JCO)
The best screening test is the one that gets followed up on
Commentary emphasizes that screening effectiveness depends on timely follow-up after positive results. (Gastroenterology)

💙 Living with CRC

Survivorship, quality of life, and supportive care

Wearables may predict treatment side effects
Study of 720 cancer patients found heart rate variability, steps, and sleep from wearables may help predict severe toxicity during treatment. (Crit Rev Oncol Hematol)

These advances in screening technology and supportive care continue to improve early detection and quality of life for the colorectal cancer community.

CRC Research Update

Subscribe to The CRC Digest